Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Features

Should We Be Looking for ‘Occlusion MI’ Rather Than STEMI?

Todd Neale

May 19, 2025

News Features

Going Solo: Can TAVI Be Performed Without a Surgical Safety Net?

Michael O'Riordan

January 22, 2024

News Features

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

L.A. McKeown

December 02, 2022

News Features

From Mountains to Meds: A Grassroots Effort Is Restocking Cath Labs in Ukraine

L.A. McKeown

October 18, 2022

News Features

As TAVI Turns 20, How Has the Heart Team Evolved?

Yael L. Maxwell

May 04, 2022

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

News Features

Cath Lab Teams Find Enduring Lessons in COVID-19’s Unending Reign

L.A. McKeown

December 20, 2021

News Features

US Chest Pain Guidelines Will Change Practice, Though Gaps Remain

Yael L. Maxwell

December 06, 2021

News Features

Cardiac Care Feels Staffing Crunch as Big Money Converts COVID-19 Travelers

Shelley Wood

January 20, 2021

News Features

Cardiology After COVID-19: Physicians Predict Lasting Change

Yael L. Maxwell

May 20, 2020

News Features

Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes

Michael O'Riordan

May 12, 2020

News Features

Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms

Caitlin E. Cox

April 23, 2020

News Features

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

Michael O'Riordan

April 07, 2020

News Features

The Mystery of the Missing STEMIs During the COVID-19 Pandemic

Shelley Wood

April 02, 2020

News Features

The Cancer Patient Needing PCI Poses Conundrums for Care

Shelley Wood

January 14, 2020

News Features

Year in Review: Low-Risk TAVR Trials Big in 2019, but QoL Data Impresses, Too

Michael O'Riordan

December 18, 2019

News Features

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

Michael O'Riordan

December 09, 2019

News Features

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

Todd Neale

June 08, 2018

Advertisement

Should We Be Looking for ‘Occlusion MI’ Rather Than STEMI?

Going Solo: Can TAVI Be Performed Without a Surgical Safety Net?

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

From Mountains to Meds: A Grassroots Effort Is Restocking Cath Labs in Ukraine

As TAVI Turns 20, How Has the Heart Team Evolved?

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Cath Lab Teams Find Enduring Lessons in COVID-19’s Unending Reign

US Chest Pain Guidelines Will Change Practice, Though Gaps Remain

Cardiac Care Feels Staffing Crunch as Big Money Converts COVID-19 Travelers

Cardiology After COVID-19: Physicians Predict Lasting Change

Hospitals Plan Cautious Restart to Elective Procedures as COVID-19 Wanes

Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

The Mystery of the Missing STEMIs During the COVID-19 Pandemic

The Cancer Patient Needing PCI Poses Conundrums for Care

Year in Review: Low-Risk TAVR Trials Big in 2019, but QoL Data Impresses, Too

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

The M Word: Is Routine Transfemoral PCI Defensible in 2018?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content